List of generic drug patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10004703 Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA	Patent 10004703 was granted and assigned to Biogen on June, 2018 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	10004703	June 26, 2018
‌ US Patent 8410928 Systems and methods for evaluating chromatography column performance	Patent 8410928 was granted and assigned to Biogen on April, 2013 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8410928	April 2, 2013
‌ US Patent 10441556 Composition containing glibenclamide	Patent 10441556 was granted and assigned to Biogen on October, 2019 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	10441556	October 15, 2019
‌ US Patent 7700097 Purification and preferential synthesis of binding molecules	Patent 7700097 was granted and assigned to Biogen on April, 2010 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	7700097	April 20, 2010
‌ US Patent 8084026 Multispecific binding molecules comprising connecting peptides	Patent 8084026 was granted and assigned to Biogen on December, 2011 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8084026	December 27, 2011
‌ US Patent 8147829 Anti-IGR-1R antibodies and uses thereof	Patent 8147829 was granted and assigned to Biogen on April, 2012 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8147829	April 3, 2012
‌ US Patent 8992924 Anti-α	Patent 8992924 was granted and assigned to Biogen on March, 2015 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8992924	March 31, 2015
‌ US Patent 7943742 Anti-α	Patent 7943742 was granted and assigned to Biogen on May, 2011 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	7943742	May 17, 2011
‌ US Patent 8168190 HBV core antigen particles with multiple immunogenic components attached via peptide ligands	Patent 8168190 was granted and assigned to Biogen on May, 2012 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	8168190	May 1, 2012
‌ US Patent 7459537 Anti-lymphotoxin-β receptor antibodies as anti-tumor agents	Patent 7459537 was granted and assigned to Biogen on December, 2008 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	7459537	December 2, 2008
‌ US Patent 11304963 Methods of medical treatment with SUR1-TRPM4 channel inhibitors		Biogen	Biogen	United States Patent and Trademark Office	11304963	April 19, 2022
‌ US Patent 10940274 Nasal spray assembly	Patent 10940274 was granted and assigned to Cipla on March, 2021 by the United States Patent and Trademark Office.	Cipla	Cipla	United States Patent and Trademark Office	10940274	March 9, 2021
‌ US Patent 10345602 Microdisplay based immersive headset	Patent 10345602 was granted and assigned to Sun Pharmaceutical on July, 2019 by the United States Patent and Trademark Office.	EMagin	Sun Pharmaceutical	United States Patent and Trademark Office	10345602	July 9, 2019
‌ US Patent 7612178 Anti-IGF-1R antibodies and uses thereof	Patent 7612178 was granted and assigned to Biogen on November, 2009 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	7612178	November 3, 2009
‌ US Patent 11292826 Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases	Patent 11292826 was granted and assigned to Biogen on April, 2022 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	11292826	April 5, 2022
‌ US Patent 9522174 Stable liquid interferon beta formulations	Patent 9522174 was granted and assigned to Biogen on December, 2016 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	9522174	December 20, 2016
‌ US Patent 7482471 Process for preparation of 1-[9H-carbazol-4-yloxy]-3-[{2-(2-(-methoxy)phenoxy)-ethyl}-amino]-propan-2-ol	Patent 7482471 was granted and assigned to Sun Pharmaceutical on January, 2009 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7482471	January 27, 2009
‌ US Patent 11333670 Methods of treating inflammatory and autoimmune diseases with natalizumab	Patent 11333670 was granted and assigned to Biogen on May, 2022 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	11333670	May 17, 2022
‌ US Patent 9974770 Formulations comprising triptan compounds	Patent 9974770 was granted and assigned to Dr. Reddy's Laboratories on May, 2018 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9974770	May 22, 2018
‌ US Patent 7427403 Methods for inhibiting lymphotoxin β receptor signalling	Patent 7427403 was granted and assigned to Biogen on September, 2008 by the United States Patent and Trademark Office.		Biogen	United States Patent and Trademark Office	7427403	September 23, 2008
‌ US Patent 8006695 Inhaler	Patent 8006695 was granted and assigned to Cipla on August, 2011 by the United States Patent and Trademark Office.		Cipla	United States Patent and Trademark Office	8006695	August 30, 2011
‌ US Patent 10444234 Assay for JC virus antibodies	Patent 10444234 was granted and assigned to Biogen on October, 2019 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	10444234	October 15, 2019
‌ US Patent 11280793 Anti-VLA-4 related assays	Patent 11280793 was granted and assigned to Biogen on March, 2022 by the United States Patent and Trademark Office.	Biogen	Biogen	United States Patent and Trademark Office	11280793	March 22, 2022
‌ US Patent 11642451 Medical injection device packaging	Patent 11642451 was granted and assigned to Teva Pharmaceutical Industries on May, 2023 by the United States Patent and Trademark Office.	Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	United States Patent and Trademark Office	11642451	May 9, 2023
‌ US Patent 11504345 Extended release liquid compositions of metformin	Patent 11504345 was granted and assigned to Sun Pharmaceutical on November, 2022 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	11504345	November 22, 2022

...

Results per page:

903 results

0 selected

903 results

0 selected